Headline Details

Gilead 4th-qtr profit quadruples, $3.84 bln in hep C drug sales

Published on: Tue, 03 Feb 2015 21:28:10 UTC
News Agency: Reuters
Feb 3 (Reuters) - Gilead Sciences Inc posted strong quarterly sales of its hepatitis C drugs Harvoni and Sovaldi, sending the drugmaker's net profit up more than four-fold for the quarter.

Click here for FULL Story on Reuters

Also happening now

HeadlineNews Agency
Saudi camel beauty pageant cracks down on cosmetic enhancements BBC
Sauti Sol singer Chimano hailed in Kenya for coming out as gay BBC
Human remains found in car linked to 45-year-old cold case BBC
China warns nations will 'pay price' for Olympic boycott BBC
Farm laws: India farmers end protest after government accepts demands BBC